State to receive $35M from settlement with Pfizer
Published: August 11,2014
Tags: Attorney General's Office, court, drug, Jim Hood, justice, lawsuit, medical, medicine, organ transplant, Pfizer Inc. health care, pharmaceutical, Rapamune, settlement, State of Mississippi, Wyeth Pharmaceuticals Inc.
JACKSON — Mississippi will receive $532,675 part of a $35 million settlement with a Pfizer Inc. subsidiary over the marketing of an organ-transplant drug.
Mississippi and 41 other states are involved in the settlement with Pfizer, the parent company of Wyeth Pharmaceuticals Inc. The deal resolves allegations Wyeth misrepresented the uses of the drug Rapamune.
A statement from Mississippi Attorney General Jim Hood says “state consumer protection laws were violated by misrepresentation of the uses and benefits of Rapamune.”
Rapamune was approved to help prevent the rejection of kidney transplants. The states alleged the company promoted it to doctors for uses following other organ transplants.
New York-based Pfizer says in a statement the alleged activity occurred before it acquired Wyeth. Pfizer didn’t admit wrongdoing or liability as part of the settlement.
To sign up for Mississippi Business Daily Updates, click here.
Top Posts & Pages
- Spivey named Under 40 Business Person of the Year by the Mississippi Business Journal
- Bids on reworking Interstate 55 stretch are rejected
- JACK WEATHERLY: Economic development in these parts is a ‘family’ business
- Two new casinos like the odds on Mississippi Gulf Coast
- The leadership styles of President Obama
- WRESTLING SUCCESS — Ted DiBiase Jr. leaves ring to become entrepreneur
- JACK WEATHERLY: Finding a house, defending a neighborhood, finding a voice
- Report ranks state schools' performance 51st in the nation
- Nehi Bottling Company has been a Cleveland fixture for 85 years